BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23811420)

  • 1. Caveat emptor? Meta-analysis of studies comparing self-observed therapy and directly observed therapy for tuberculosis.
    Moonan PK; Weis SE
    Clin Infect Dis; 2013 Oct; 57(7):1062-3. PubMed ID: 23811420
    [No Abstract]   [Full Text] [Related]  

  • 2. An analysis with serious flaws.
    Nunn AJ; Phillips PP
    Clin Infect Dis; 2013 Oct; 57(7):1064-5. PubMed ID: 23811419
    [No Abstract]   [Full Text] [Related]  

  • 3. First do no harm--adverse events, drug intolerance, and hepatotoxicity: how can we not justify directly observed therapy for treating tuberculosis?
    Seaworth BJ; Armitige LY; Griffith DE
    Clin Infect Dis; 2013 Oct; 57(7):1063-4. PubMed ID: 23811418
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Moonan and Weis, Seaworth et al, and Nunn and Phillips.
    Pasipanodya JG; Gumbo T
    Clin Infect Dis; 2013 Oct; 57(7):1065-6. PubMed ID: 23811417
    [No Abstract]   [Full Text] [Related]  

  • 5. A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients.
    Pasipanodya JG; Gumbo T
    Clin Infect Dis; 2013 Jul; 57(1):21-31. PubMed ID: 23487389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trench warfare in a battle with TB.
    Marshall E
    Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract]   [Full Text] [Related]  

  • 7. Could Killing Bacterial Subpopulations Hit Tuberculosis out of the Park?
    Baranowski C; Rubin EJ
    J Med Chem; 2016 Jul; 59(13):6025-6. PubMed ID: 27322073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hospital infection caused by multi-drug-resistant Mycobacterium tuberculosis].
    Watanabe A
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():117-21. PubMed ID: 12717957
    [No Abstract]   [Full Text] [Related]  

  • 9. Doubts about DOTS.
    Davies GR; Squire SB
    BMJ; 2008 Mar; 336(7642):457-8. PubMed ID: 18250103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Children and multidrug-resistant tuberculosis in Mumbai (Bombay), India.
    Karande S; Bavdekar SB
    Emerg Infect Dis; 2002 Nov; 8(11):1360-1. PubMed ID: 12453371
    [No Abstract]   [Full Text] [Related]  

  • 11. Joining the DOTS: National "twin study".
    Dahle UR
    BMJ; 2008 Mar; 336(7644):574. PubMed ID: 18340053
    [No Abstract]   [Full Text] [Related]  

  • 12. Is this the time to revise the Revised National Tuberculosis Control Programme in India?--yes and no..
    Jindal SK; Agarwal R
    Natl Med J India; 2008; 21(4):159-62. PubMed ID: 19267034
    [No Abstract]   [Full Text] [Related]  

  • 13. New strategies of tuberculosis control in the developing world.
    Enarson DA
    Pediatr Pulmonol; 2001; Suppl 23():67-9. PubMed ID: 11886153
    [No Abstract]   [Full Text] [Related]  

  • 14. A family cluster of tuberculosis cases, including a case of acquired multidrug resistant tuberculosis.
    Holden J; Trachtman L
    J La State Med Soc; 2012; 164(1):43-7. PubMed ID: 22533114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis deaths averted by implementation of the DOTS strategy in Kazakhstan.
    Favorov M; Belilovsky E; Aitmagambetova I; Ismailov S; White ME; Chorba T
    Int J Tuberc Lung Dis; 2010 Dec; 14(12):1582-8. PubMed ID: 21144244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Monitor-supervised family member' DOT: an optimal means of delivering DOT.
    Moulding TS
    Int J Tuberc Lung Dis; 2007 Dec; 11(12):1380-1. PubMed ID: 18034962
    [No Abstract]   [Full Text] [Related]  

  • 17. Managing TB in the 21st century: existing and novel drug therapies.
    Guy ES; Mallampalli A
    Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An attempt to reproduce a previous meta-analysis and a new analysis regarding the impact of directly observed therapy on tuberculosis treatment outcomes.
    McKay B; Castellanos M; Ebell M; Whalen CC; Handel A
    PLoS One; 2019; 14(5):e0217219. PubMed ID: 31120965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimising moxifloxacin resistance with tuberculosis.
    Drlica K; Zhao X; Kreiswirth B
    Lancet Infect Dis; 2008 May; 8(5):273-5. PubMed ID: 18471768
    [No Abstract]   [Full Text] [Related]  

  • 20. Tuberculosis drug resistance mutation database.
    Sandgren A; Strong M; Muthukrishnan P; Weiner BK; Church GM; Murray MB
    PLoS Med; 2009 Feb; 6(2):e2. PubMed ID: 19209951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.